Navigation Links
Early detection of lung cancer: New data presented at multidisciplinary meeting
Date:5/2/2009

New data from several studies evaluating new techniques for early diagnosis and treatment of lung cancer are being presented at the first European Multidisciplinary Conference on Thoracic Oncology (EMCTO) in Lugano, Switzerland (1-3 May 2009).

"Lung cancer is the leading cause of cancer deaths worldwide and also in Europe. One of the reasons for this is that symptoms of lung cancer are very often lacking or occur only late in the course of the disease," said Prof Rudolf M. Huber from the University of Munich in Germany.

"The prognosis of lung cancer patients is very dependent on how advanced their disease is. In stage I for example, where the tumour has not yet spread, 5-year-survival rates are about 70%; whereas in stage IV, where it has metastasised to other parts of the body, survival is about 1%. Even for patients with locally advanced tumours, survival over 5 years is only about 10%. Therefore every effort should be undertaken to diagnose early in the course of the disease."

"Developing better tools for distinguishing between lung cancer and other lung diseases will help us offer greater hope for patients," added Prof Huber.

In one study presented at the conference, Italian researchers compare two computed tomography techniques for diagnosing indeterminate lung lesions, finding that a form of single-photon emission computed tomography could offer an alternative method in situations where positron emission tomography is not available.

In another abstract, UK scientists report that a new approach to diagnosis that ensures a patient has had a chest CT scan before they attend a clinic has the potential to reduce the time between their first abnormal chest X-ray and final diagnosis.

Also during the conference, Greek investigators suggest that they may have found a new factor that will help indicate a patient's prognosis at the time of diagnosis. Their work indicates that the expression of specific cell surface molecules on tumour cells correlates with clinical parameters. The results "could comprise a promising prognostic factor in lung carcinomas, thus presenting exciting possibilities for the future."


'/>"/>

Contact: ESMO Press Office
media@esmo.org
41-919-731-907
European Society for Medical Oncology
Source:Eurekalert

Related biology news :

1. Google Earth aids discovery of early African mammal fossils
2. Early brain activity sheds new light on the neural basis of reading
3. Early isolation linked to enhanced response to cocaine
4. Early isolation linked to enhanced response to cocaine
5. Early administration of antiretroviral therapy can improve survival
6. Compendium of pancreatic cancer biomarkers established as strategic approach to early-detection
7. Novel lung cancer vaccine shows promise in fighting early-stage lung cancer
8. Early family ties: No sponge in the human family tree
9. Two innovative University of Texas at Austin biologists become HHMI Early Career Scientists
10. Two Hutchinson Center researchers named HHMI Early Career Scientists
11. Peter Baumann named Howard Hughes Medical Institute Early Career Scientist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
(Date:12/15/2016)... AUBURN HILLS, Mich. , Dec. 15, 2016 /PRNewswire/ ... simply unlocking car doors or starting the engine. Continental ... 2017 in Las Vegas . Through ... PASE (Passive Start and Entry) and biometric elements, the ... the field of vehicle personalization and authentication. ...
(Date:12/8/2016)... Dec. 8, 2016 Market Research Future published a half ... global Mobile Biometric Security and Service Market is expected to grow ... Market Highlights: ... , Mobile Biometric Security and ... the increasing need of authentication and security from unwanted cyber threats. ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... Researchers from a new study are stating ... low enough after prostate cancer treatment, this indicates there is still remaining prostate cancer cells ... , “ The PSA test has always been an indicator of whether a man’s prostate ...
(Date:1/18/2017)... ... January 18, 2017 , ... BidMed, ... sell research and genetic testing lab equipment from two different leading institutes. This highly ... Northeast regions of the United States. This 1-day online auction will take place ...
(Date:1/18/2017)... ... January 18, 2017 , ... Thirty-six startup companies in ... by the Pennsylvania Department of Community and Economic Development in 2016 as part of ... in the University City Keystone Innovation Zone and represent the highest number of awards ...
(Date:1/18/2017)... SAN DIEGO , Jan. 18, 2017  HUYA ... development of China,s pharmaceutical innovations, ... Academy of Sciences Innovation and Investment Company (referred to ... and commercializing biomedical innovations discovered by leading scientists at ... the world. HUYA is the first company ...
Breaking Biology Technology: